SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 9th, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of October 9, 2020 (the “Effective Date”) by and among MedAvail, Inc., a Delaware corporation (the “Company”), and the purchasers listed on the signature pages hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in SECTION 9 hereof.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • October 9th, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is entered into as of __________, 2020 by and among MedAvail, Inc., a Delaware corporation (the “Company”), the Prior Holders, and certain persons and entities listed on Exhibit A attached hereto (collectively with the Prior Holders, the “Investors”), and upon delivery of a duly executed joinder, MYOS RENS TECHNOLOGY, Inc. (“MYOS”).
